(Q40531384)

English

A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation.

scientific article published on July 2004

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

William Ying Khee Hwang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Koh LP

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Ng HJ

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Tan PH

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Chuah CT

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Fook SC

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Chow H

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Tan KW

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Wong C

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Tan CH

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Goh YT

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

0 references

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

51-56

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Amifostine (WR-2721) Protects Normal Haematopoietic Stem Cells Against Cyclophosphamide Derivatives' Toxicity Without Compromising Their Antileukaemic Effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Does amifostine have a role in chemoradiation treatment?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Down-regulation of intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides a strong basis for explaining amifostine selectivity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Ex vivo pharmacological purging of leukapheresis collections with nitrogen mustard: amifostine pretreatment improves both early and late peripheral blood progenitor cell recovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase II study of amifostine used as stem cell protectant in non-hodgkin lymphoma patients receiving cisplatin-based salvage chemotherapy prior to stem cell transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of amifostine on reconstitution of lymphocyte subpopulations after conventional- and high-dose chemotherapy in patients with germ cell tumor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of WR-2721.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention and management of oral infections in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704521

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704521

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15208650%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40531384&oldid=2203763446"